Lu AG06479
/ Lundbeck
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
December 14, 2021
Safety and Tolerability of Lu AG06479 in Healthy Young Men
(clinicaltrials.gov)
- P1; N=46; Terminated; Sponsor: H. Lundbeck A/S; N=66 ➔ 46; Recruiting ➔ Terminated; The study was terminated for strategic reasons.
Clinical • Enrollment change • Trial termination
September 27, 2021
Safety and Tolerability of Lu AG06479 in Healthy Young Men
(clinicaltrials.gov)
- P1; N=66; Recruiting; Sponsor: H. Lundbeck A/S; Trial completion date: Apr 2021 ➔ Jan 2022; Trial primary completion date: Apr 2021 ➔ Jan 2022
Clinical • Trial completion date • Trial primary completion date
July 16, 2020
Safety and Tolerability of Lu AG06479 in Healthy Young Men
(clinicaltrials.gov)
- P1; N=66; Recruiting; Sponsor: H. Lundbeck A/S
Clinical • New P1 trial
1 to 3
Of
3
Go to page
1